• Profile
Close

Adverse maternal and neonatal outcomes among low-risk women with obesity at 37-41 weeks gestation

European Journal of Obstetrics & Gynecology and Reproductive Biology Sep 17, 2020

Bicocca MJ, Gupta M, Wagner SM, et al. - Using US vital statistics data from 2014-2017, researchers conducted this population-based retrospective cohort study to assess adverse neonatal and maternal outcomes among women with obesity and no additional comorbidities at 37 to 41 weeks. Participants in the study were women with BMI ≥ 30.0 kg/m2 and a singleton, cephalic, non-anomalous pregnancy who attempted labor and delivered between 37 0/7 - 41 6/7 weeks. Women with chronic hypertension, gestational diabetes, or pregestational diabetes have been eliminated. Between 2014-2017, there were 15.8 million live births, of whom 5.1 million (32.1%) met the criteria for inclusion. According to results, composite neonatal and maternal morbidity among women with obesity and no additional comorbidities was increased with delivery at 37, 38, 40, or 41 weeks as compared to 39 weeks.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay